News from Kymab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

24 Nov, 2016, 04:00 ET Kymab Secures US$100 Million Series C Funding

Kymab Group Limited ("Kymab"), a leading monoclonal antibody biopharmaceutical group, announced today that it has successfully secured a US$100...


09 Sep, 2016, 03:00 ET Kymouse™, Kymab's Human Antibody Discovery Platform, Successfully Demonstrates Steps to Developing HIV Vaccine

Kymab, The Scripps Research Institute and International AIDS Vaccine Initiative Collaboration Improves Discovery and Testing of Promising HIV...


07 Jan, 2016, 04:00 ET Kymab and MD Anderson Announce Strategic Partnership in Immuno-Oncology Research & Development

Kymab, the leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson's Oncology Research for Biologics...


16 May, 2014, 06:49 ET Kymab Secures US$40 Million Investment From Two of the Largest Foundations in the World to Advance Clinical Development of Antibody Therapeutics

Series B Financing includes the Wellcome Trust and the Bill & Melinda Gates Foundation  Kymab, a monoclonal antibody biopharmaceutical...


09 Oct, 2013, 11:39 ET Kymab Defends Patent Action in UK

Kymab, a monoclonal antibody biopharmaceutical company, announces today it has notified the English Court that it will defend the UK patent...


22 Apr, 2013, 03:00 ET Kymab Announces Kymouse Antibody Discovery Agreement With Novo Nordisk

Kymab, a monoclonal antibody biopharmaceutical company, announced today an agreement in therapeutic antibody discovery. Novo Nordisk has been...


18 Sep, 2012, 03:30 ET Kymab Announces Launch of Kymouse HK

First human antibody strain from its advanced discovery platform Kymab, a monoclonal antibody biopharmaceutical company, announced today the...